Medison Pharma
Medison Pharma, a leading global biopharmaceutical company headquartered in Israel, has been at the forefront of innovative healthcare solutions since its establishment in 2003. With a strong presence in Europe, Asia, and North America, Medison Pharma focuses on the development and commercialisation of advanced therapies, particularly in oncology and rare diseases. The company is renowned for its unique portfolio of products, which includes cutting-edge biologics and specialty pharmaceuticals that address unmet medical needs. Medison Pharma's commitment to quality and patient-centric solutions has positioned it as a trusted partner in the biopharmaceutical industry. Notable achievements include strategic collaborations with major pharmaceutical firms, enhancing its market position and expanding access to life-saving treatments worldwide.
DitchCarbon Score
How does Medison Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Education Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medison Pharma's score of 23 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medison Pharma's reported carbon emissions
Medison Pharma, headquartered in Israel (IL), currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies are encouraged to adopt science-based targets and engage in climate pledges to mitigate their environmental impact. Medison Pharma may be aligning with these industry trends, but specific details on their climate commitments or emissions data are not provided.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medison Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
